{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:05Z","timestamp":1787020745914,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Astellas Gene Therapies"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>X-linked myotubular myopathy (XLMTM) is a rare, life-threatening congenital myopathy with multisystem involvement, which often includes the need for invasive ventilator support, gastrostomy tube feeding, and wheelchair use in approximately 80% of patients. The direct and indirect financial impact of extensive supportive care, as reported by caregivers of individuals with XLMTM, and the health-related quality of life (HRQoL) of caregivers has not been previously described. Here, we use a survey co-designed by patient advocates to provide objective information on the physical and financial challenges of caregiving for individuals with XLMTM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A real-world web-based survey was conducted in the United States between November 19, 2019, and January 23, 2020. The survey was developed in association with patient advocacy leaders from the XLMTM community, who were also caregivers of individuals with XLMTM. The survey included the EuroQol 5-dimension 5-level HRQoL instrument and visual analog scale, and a cost (direct and indirect medical costs) and healthcare resource questionnaire. The survey was shared among the XLMTM community by patient advocacy organizations. Caregivers who completed the survey and met the eligibility criteria were included. Descriptive statistics were conducted using Microsoft Excel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-two caregiver respondents agreed to participate. All respondents completed the cost and health resource survey. Productivity loss varied between participants over the prior 12\u00a0months. Durable medical equipment expenses comprised most of the direct medical out-of-pocket costs. Non-medical expenditures (e.g. home and vehicle modifications) were higher than direct medical out-of-pocket costs. Twelve of the 22 respondents completed the HRQoL survey. The HRQoL domains most impacted were usual activities, anxiety\/depression, and pain\/discomfort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings from this real-world survey of caregivers for individuals with XLMTM describe the caregiver experience, as well as the multifaceted impact of the disease on caregiver productivity loss, out-of-pocket expenses, and HRQoL. XLMTM comes with financial constraints and substantial impacts on caregivers\u2019 physical and mental health. Understanding these gaps is crucial to support the caregivers who provide care for this medically fragile population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03583-w","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T04:52:18Z","timestamp":1747025538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A real-world analysis of the impact of X-linked myotubular myopathy on caregivers in the United States"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3177-4722","authenticated-orcid":false,"given":"Tina","family":"Duong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tmirah","family":"Haselkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beckley","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"2","key":"3583_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/jnen\/nlv020","volume":"75","author":"MW Lawlor","year":"2016","unstructured":"Lawlor MW, Beggs AH, Buj-Bello A, et al. Skeletal muscle pathology in X-linked myotubular myopathy: review with cross-species comparisons. J Neuropathol Exp Neurol. 2016;75(2):102\u201310.","journal-title":"J Neuropathol Exp Neurol."},{"key":"3583_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jbior.2016.09.001","volume":"63","author":"MA Raess","year":"2017","unstructured":"Raess MA, Friant S, Cowling BS, Laporte J. WANTED \u2013 dead or alive: myotubularins, a large disease-associated protein family. Adv Biol Regul. 2017;63:49\u201358.","journal-title":"Adv Biol Regul."},{"issue":"9","key":"3583_CR3","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/hmg\/ddt038","volume":"22","author":"R Joubert","year":"2013","unstructured":"Joubert R, Vignaud A, Le M, Moal C, Messaddeq N, Buj-Bello A. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle. Hum Mol Genet. 2013;22(9):1856\u201366.","journal-title":"Hum Mol Genet."},{"issue":"4","key":"3583_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/mus.26018","volume":"57","author":"AH Beggs","year":"2018","unstructured":"Beggs AH, Byrne BJ, De Chastonay S, et al. A multicenter, retrospective medical record review of X-linked myotubular myopathy: the recensus study. Muscle Nerve. 2018;57(4):550\u201360.","journal-title":"Muscle Nerve"},{"key":"3583_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1172-3-26","volume":"3","author":"H Jungbluth","year":"2008","unstructured":"Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis. 2008;3:26.","journal-title":"Orphanet J Rare Dis."},{"issue":"10","key":"3583_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0960-8966(02)00153-0","volume":"12","author":"M McEntagart","year":"2002","unstructured":"McEntagart M, Parsons G, Buj-Bello A, et al. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord. 2002;12(10):939\u201346.","journal-title":"Neuromuscul Disord."},{"issue":"9","key":"3583_CR7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.nmd.2018.06.012","volume":"28","author":"I Vandersmissen","year":"2018","unstructured":"Vandersmissen I, Biancalana V, Servais L, et al. An integrated modelling methodology for estimating the prevalence of centronuclear myopathy. Neuromuscul Disord. 2018;28(9):766\u201377.","journal-title":"Neuromuscul Disord."},{"issue":"4","key":"3583_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/archdischild-2019-317910","volume":"105","author":"RJ Graham","year":"2020","unstructured":"Graham RJ, Muntoni F, Hughes I, et al. Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis. Arch Dis Child. 2020;105(4):332\u20138.","journal-title":"Arch Dis Child"},{"issue":"4","key":"3583_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5535\/arm.2017.41.4.519","volume":"41","author":"JR Bach","year":"2017","unstructured":"Bach JR. Noninvasive respiratory management of patients with neuromuscular disease. Ann Rehabil Med. 2017;41(4):519\u201338.","journal-title":"Ann Rehabil Med."},{"issue":"3","key":"3583_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/0883073812436605","volume":"27","author":"CH Wang","year":"2012","unstructured":"Wang CH, Dowling JJ, North K, et al. Consensus statement on standard of care for congenital myopathies. J Child Neurol. 2012;27(3):363\u201382.","journal-title":"J Child Neurol."},{"issue":"8","key":"3583_CR11","first-page":"1019","volume":"27","author":"NC Sacks","year":"2021","unstructured":"Sacks NC, Healey BE, Cyr PL, et al. Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims. J Manag Care Spec Pharm. 2021;27(8):1019\u201326.","journal-title":"J Manag Care Spec Pharm."},{"key":"3583_CR12","unstructured":"Dowling JJ, Lawlor MW, Das S. X-linked myotubular myopathy. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, et al., editors. GeneReviews\u00ae. Seattle, Washington: University of Washington; 2018"},{"issue":"1","key":"3583_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JND-210712","volume":"9","author":"C Molera","year":"2022","unstructured":"Molera C, Sarishvili T, Nascimento A, et al. Intrahepatic cholestasis is a clinically significant feature associated with matural history of X-linked myotubular myopathy (XLMTM): a case series and biopsy report. J Neuromuscul Dis. 2022;9(1):73\u201382.","journal-title":"J Neuromuscul Dis"},{"issue":"13","key":"3583_CR14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1212\/WNL.0000000000004415","volume":"89","author":"K Amburgey","year":"2017","unstructured":"Amburgey K, Tsuchiya E, de Chastonay S, et al. A natural history study of X-linked myotubular myopathy. Neurology. 2017;89(13):1355\u201364.","journal-title":"Neurology"},{"issue":"5","key":"3583_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337\u201343.","journal-title":"Ann Med"},{"key":"3583_CR16","unstructured":"U.S. Bureau of Labor Statistics. Civilian workers by occupational and industry group. 2023. https:\/\/www.bls.gov\/news.release\/ecec.t02.htm. Accessed 6 Dec 2023."},{"issue":"3","key":"3583_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11136-020-02650-y","volume":"30","author":"R Jiang","year":"2021","unstructured":"Jiang R, Janssen MFB, Pickard AS. US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples. Qual Life Res. 2021;30(3):803\u201316.","journal-title":"Qual Life Res"},{"issue":"5","key":"3583_CR18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B van Hout","year":"2012","unstructured":"van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708\u201315.","journal-title":"Value Health"},{"issue":"9","key":"3583_CR19","first-page":"837","volume":"40","author":"B Pennington","year":"2022","unstructured":"Pennington B, Eaton J, Hatswell AJ, Taylor H. Carers\u2019 health-related quality of life in global health technology assessment: guidance. Case Stud Recommendat Pharmacoec. 2022;40(9):837\u201350.","journal-title":"Case Stud. Recommendat. Pharmacoec."},{"issue":"10","key":"3583_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/01.jom.0000141830.72507.32","volume":"46","author":"WN Burton","year":"2004","unstructured":"Burton WN, Chen CY, Conti DJ, Pransky G, Edington DW. Caregiving for ill dependents and its association with employee health risks and productivity. J Occup Environ Med. 2004;46(10):1048\u201356.","journal-title":"J Occup Environ Med."},{"issue":"2","key":"3583_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ncl.2022.11.001","volume":"41","author":"RE Norris","year":"2023","unstructured":"Norris RE. Are America\u2019s caregivers on the brink of extinction? The pandemic straw that broke the burses\u2019 back. Neurol Clin. 2023;41(2):415\u201323.","journal-title":"Neurol Clin."},{"key":"3583_CR22","unstructured":"Haddad LM, Annamaraju P, Toney-Butler TJ. Nursing shortage. StatPearls. Treasure Island (FL); StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493175\/."},{"issue":"3","key":"3583_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.25259\/IJPC_179_2022","volume":"29","author":"A Katsarou","year":"2023","unstructured":"Katsarou A, Intas G, Pierrakos G. Investigating the needs of caregivers of patients suffering from chronic diseases: a mixed-method study. Indian J Palliat Care. 2023;29(3):285\u201391.","journal-title":"Indian J Palliat Care"},{"issue":"1","key":"3583_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1310\/GN0J-EXVX-KX0B-8X43","volume":"9","author":"T Bakas","year":"2002","unstructured":"Bakas T, Burgener SC. Predictors of emotional distress, general health, and caregiving outcomes in family caregivers of stroke survivors. Top Stroke Rehabil. 2002;9(1):34\u201345.","journal-title":"Top Stroke Rehabil."},{"key":"3583_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13030-019-0147-2","volume":"13","author":"F Toledano-Toledano","year":"2019","unstructured":"Toledano-Toledano F, Dominguez-Guedea MT. Psychosocial factors related with caregiver burden among families of children with chronic conditions. Biopsychosoc Med. 2019;13:6.","journal-title":"Biopsychosoc Med."},{"issue":"8","key":"3583_CR26","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/gerona\/glaa017","volume":"75","author":"L Jacob","year":"2020","unstructured":"Jacob L, Oh H, Shin JI, et al. Informal caregiving, chronic physical conditions, and physical multimorbidity in 48 low- and middle-income countries. J Gerontol A Biol Sci Med Sci. 2020;75(8):1572\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"3","key":"3583_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0883073820962927","volume":"36","author":"JL Jackson","year":"2021","unstructured":"Jackson JL, Korth CX, Leslie CE, et al. Health-related quality of life and emotional distress among mothers of sons with muscular dystrophy as compared to sex- and age group-matched controls. J Child Neurol. 2021;36(3):177\u201385.","journal-title":"J Child Neurol."},{"issue":"5","key":"3583_CR28","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s00415-016-8080-9","volume":"263","author":"E Landfeldt","year":"2016","unstructured":"Landfeldt E, Lindgren P, Bell CF, et al. Quantifying the burden of caregiving in Duchenne muscular dystrophy. J Neurol. 2016;263(5):906\u201315.","journal-title":"J Neurol"},{"issue":"1","key":"3583_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/brainsci13010110","volume":"13","author":"C Wohnrade","year":"2023","unstructured":"Wohnrade C, Velling AK, Mix L, et al. Health-related quality of life in spinal muscular atrophy patients and their caregivers: a prospective, cross-sectional, multi-center analysis. Brain Sci. 2023;13(1):110.","journal-title":"Brain Sci"},{"issue":"4","key":"3583_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nmd.2019.02.011","volume":"29","author":"CH Cremers","year":"2019","unstructured":"Cremers CH, Fischer MJ, Kruitwagen-van Reenen ET, et al. Participation and mental well-being of mothers of home-living patients with spinal muscular atrophy. Neuromuscul Disord. 2019;29(4):321\u20139.","journal-title":"Neuromuscul Disord."},{"issue":"1","key":"3583_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s41687-021-00386-y","volume":"5","author":"CE Schwartz","year":"2021","unstructured":"Schwartz CE, Stark RB, Audhya IF, Gooch KL. Characterizing the quality-of-life impact of Duchenne muscular dystrophy on caregivers: a case-control investigation. J Patient Rep Outcomes. 2021;5(1):124.","journal-title":"J Patient Rep Outcomes"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03583-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T04:52:20Z","timestamp":1747025540000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03583-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3583"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03583-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey design and content were reviewed and approved by the Advarra Institutional Review Board to be used for scientific purposes. The survey was conducted according to the principles expressed in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TD is a consultant for Astellas Gene Therapies, Dyne Therapeutics, Avidity, Roche; and has participated in advisory boards for Roche, Novartis, and Biogen. TH and JC are employees of Astellas Gene Therapies. BM and IJ are employees of PRECISIONheor, a division of Precision Medicine Group, which received funding from Astellas Gene Therapies (formerly Audentes Therapeutics, Inc.) for this research. EW and MW report no competing interests. RJG reports being on the advisory board of Astellas Pharmaceuticals for X-linked myotubular myopathy and Pompe disease outside the submitted work. LS has received consulting fees from Sarepta, Pfizer, Roche, Affina, Renegex Bio, Astellas Gene Therapies (formerly Audentes Therapeutics, Inc.), Evox Therapeutics, and Novartis; has received honoraria from Sarepta, Roche, Audentes Therapeutics, Inc., and Novartis; and is the Secretary of the World Muscle Society.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}